Advertisement

Intensive Care Medicine

, 37:1865 | Cite as

High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function

  • Karen Maes
  • Dries Testelmans
  • Debby Thomas
  • Marc Decramer
  • Ghislaine Gayan-RamirezEmail author
Experimental

Abstract

Purpose

We previously showed that rocuronium combined with 24 h of controlled mechanical ventilation (CMV) leads to an additional negative effect on diaphragm function in rats. Based on clinical observations we examined whether the combination of rocuronium with corticosteroids during CMV would result into a further deterioration of diaphragm function.

Methods

Mechanically ventilated rats received intravenously a continuous infusion of saline (CMV) or rocuronium (ROC) or rocuronium combined with an intramuscular injection of 80 mg/kg of methylprednisolone (ROC-MP). After 24 h we determined diaphragm in vitro contractile properties, cross-sectional area (CSA) of the different fiber types, the MyHC/actin ratio, and proteolytic activity in diaphragm and gastrocnemius.

Results

ROC treatment resulted in a significant reduction of diaphragm force compared with CMV. Treatment with MP attenuated the ROC-induced diaphragmatic contractile dysfunction. CSA of the diaphragm type IIx/b fibers tended to decrease by 13% after ROC but not after MP. Diaphragm MuRF-1 mRNA expression increased significantly with 30% after ROC and ROC-MP compared to CMV, while MAFbx was similar in all groups. Diaphragm caspase-3 (+39%) and calpain activity (+99%) were increased after ROC compared to CMV. Treatment with MP abolished the increase in both activities. Proteolytic activity in the gastrocnemius was similar in all groups. The MyHC/actin ratio was similar in the diaphragm and the gastrocnemius in all groups.

Conclusions

The combination of ROC with a high dose of MP attenuated diaphragm dysfunction caused by ROC probably through inhibition of the calpain and caspase-3 system. None of these treatments affected the gastrocnemius.

Keywords

Mechanical ventilation Methylprednisolone Rocuronium 

Notes

Acknowledgments

The authors thank Mrs. Petra Weckx for cutting and staining the histological sections. Karen Maes is supported by FWO-Flanders.

Supplementary material

134_2011_2337_MOESM1_ESM.doc (45 kb)
Supplementary material 1 (DOC 45 kb)

References

  1. 1.
    Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW Jr, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA Jr, Lumb PD (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30:142–156PubMedCrossRefGoogle Scholar
  2. 2.
    Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32:140–163PubMedCrossRefGoogle Scholar
  3. 3.
    Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP, Bonilla E, Hays AP (1992) Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 42:2082–2087PubMedGoogle Scholar
  4. 4.
    Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ (1996) Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 40:645–654PubMedCrossRefGoogle Scholar
  5. 5.
    Lefaucheur JP, Nordine T, Rodriguez P, Brochard L (2006) Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77:500–506PubMedCrossRefGoogle Scholar
  6. 6.
    Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C (1996) Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 153:1686–1690PubMedGoogle Scholar
  7. 7.
    Friedrich O (2006) Critical illness myopathy: what is happening? Curr Opin Clin Nutr Metab Care 9:403–409PubMedCrossRefGoogle Scholar
  8. 8.
    Behbehani NA, Al Mane F, D’yachkova Y, Pare P, FitzGerald JM (1999) Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 115:1627–1631PubMedCrossRefGoogle Scholar
  9. 9.
    Nava S, Gayan-Ramirez G, Rollier H, Bisschop A, Dom R, de Bock V, Decramer M (1996) Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am J Respir Crit Care Med 153:1888–1896PubMedGoogle Scholar
  10. 10.
    Testelmans D, Maes K, Wouters P, Gosselin N, Deruisseau K, Powers S, Sciot R, Decramer M, Gayan-Ramirez G (2006) Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats. Crit Care Med 34:3018–3023PubMedGoogle Scholar
  11. 11.
    Maes K, Testelmans D, Cadot P, Deruisseau K, Powers SK, Decramer M, Gayan-Ramirez G (2008) Effects of acute administration of corticosteroids during mechanical ventilation on rat diaphragm. Am J Respir Crit Care Med 178:1219–1226PubMedCrossRefGoogle Scholar
  12. 12.
    Gayan-Ramirez G, de Paepe K, Cadot P, Decramer M (2003) Detrimental effects of short-term mechanical ventilation on diaphragm function and IGF-I mRNA in rats. Intensive Care Med 29:825–833PubMedGoogle Scholar
  13. 13.
    Dekhuijzen PN, Gayan-Ramirez G, de Bock V, Dom R, Decramer M (1993) Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest 92:1534–1542PubMedCrossRefGoogle Scholar
  14. 14.
    Powers SK, Shanely RA, Coombes JS, Koesterer TJ, McKenzie M, Van Gammeren D, Cicale M, Dodd SL (2002) Mechanical ventilation results in progressive contractile dysfunction in the diaphragm. J Appl Physiol 92:1851–1858PubMedGoogle Scholar
  15. 15.
    Sassoon CS, Caiozzo VJ, Manka A, Sieck GC (2002) Altered diaphragm contractile properties with controlled mechanical ventilation. J Appl Physiol 92:2585–2595PubMedGoogle Scholar
  16. 16.
    Hermans G, Agten A, Testelmans D, Decramer M, Gayan-Ramirez G (2010) Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study. Crit Care 14:R127PubMedCrossRefGoogle Scholar
  17. 17.
    Jaber S, Petrof BJ, Jung B, Chanques G, Berthet JP, Rabuel C, Bouyabrine H, Courouble P, Koechlin-Ramonatxo C, Sebbane M, Similowski T, Scheuermann V, Mebazaa A, Capdevila X, Mornet D, Mercier J, Lacampagne A, Philips A, Matecki S (2011) Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med 183:364–371PubMedCrossRefGoogle Scholar
  18. 18.
    Laghi F, Harrison MJ, Tobin MJ (1996) Comparison of magnetic and electrical phrenic nerve stimulation in assessment of diaphragmatic contractility. J Appl Physiol 80:1731–1742PubMedCrossRefGoogle Scholar
  19. 19.
    Watson AC, Hughes PD, Louise HM, Hart N, Ware RJ, Wendon J, Green M, Moxham J (2001) Measurement of twitch transdiaphragmatic, esophageal, and endotracheal tube pressure with bilateral anterolateral magnetic phrenic nerve stimulation in patients in the intensive care unit. Crit Care Med 29:1325–1331PubMedCrossRefGoogle Scholar
  20. 20.
    Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L, Anzueto A (2005) Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 128:496–506PubMedCrossRefGoogle Scholar
  21. 21.
    Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F, Busch T, Falke KJ, Kaisers U (2005) Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 33:711–715PubMedCrossRefGoogle Scholar
  22. 22.
    Amaya-Villar R, Garnacho-Montero J, Garcia-Garmendia JL, Madrazo-Osuna J, Garnacho-Montero MC, Luque R, Ortiz-Leyba C (2005) Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 31:157–161PubMedCrossRefGoogle Scholar
  23. 23.
    Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I (2005) Risk factors for critical illness polyneuromyopathy. J Neurol 252:343–351PubMedCrossRefGoogle Scholar
  24. 24.
    de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281–2286PubMedCrossRefGoogle Scholar
  25. 25.
    Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348–1353PubMedCrossRefGoogle Scholar
  26. 26.
    Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani MJ (1998) Acute myopathy after liver transplantation. Neurology 50:46–53PubMedGoogle Scholar
  27. 27.
    De JB, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867CrossRefGoogle Scholar
  28. 28.
    Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:683–693PubMedCrossRefGoogle Scholar
  29. 29.
    Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G (2007) Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175:480–489PubMedCrossRefGoogle Scholar
  30. 30.
    Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano-Del-Estad MR (2001) Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27:1288–1296PubMedCrossRefGoogle Scholar
  31. 31.
    Soltesz S, Mencke T, Stunz M, Diefenbach C, Ziegeler S, Molter GP (2009) Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone. Acta Anaesthesiol Scand 53:443–448PubMedCrossRefGoogle Scholar
  32. 32.
    Gutmann L, Blumenthal D, Gutmann L, Schochet SS (1996) Acute type II myofiber atrophy in critical illness. Neurology 46:819–821PubMedGoogle Scholar
  33. 33.
    Taillandier D, Aurousseau E, Meynial-Denis D, Bechet D, Ferrara M, Cottin P, Ducastaing A, Bigard X, Guezennec CY, Schmid HP, Attaix D (1996) Coordinate activation of lysosomal, Ca2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 316(Pt 1):65–72PubMedGoogle Scholar
  34. 34.
    Maes K, Testelmans D, Powers S, Decramer M, Gayan-Ramirez G (2007) Leupeptin inhibits ventilator-induced diaphragm dysfunction in rats. Am J Respir Crit Care Med 175:1134–1138PubMedCrossRefGoogle Scholar
  35. 35.
    Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T, Enns D, Belcastro A, Powers SK (2002) Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity. Am J Respir Crit Care Med 166:1369–1374PubMedCrossRefGoogle Scholar
  36. 36.
    Hussain SN, Mofarrahi M, Sigala I, Kim HC, Vassilakopoulos T, Maltais F, Bellenis I, Chaturvedi R, Gottfried SB, Metrakos P, Danialou G, Matecki S, Jaber S, Petrof BJ, Goldberg P (2010) Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med 182:1377–1386PubMedCrossRefGoogle Scholar
  37. 37.
    Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, Powers SK, Shrager JB (2008) Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 358:1327–1335PubMedCrossRefGoogle Scholar
  38. 38.
    Levine S, Biswas C, Dierov J, Barsotti R, Shrager JB, Nguyen T, Sonnad S, Kucharchzuk JC, Kaiser LR, Singhal S, Budak MT (2011) Increased proteolysis, myosin depletion, and atrophic AKT-FOXO signaling in human diaphragm disuse. Am J Respir Crit Care Med 183:483–490PubMedCrossRefGoogle Scholar
  39. 39.
    Stibler H, Edstrom L, Ahlbeck K, Remahl S, Ansved T (2003) Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 29:1515–1527PubMedCrossRefGoogle Scholar
  40. 40.
    Koerts-De Lang E, Schols AM, Wouters EF, Gayan-Ramirez G, Decramer M (1998) Contractile properties and histochemical characteristics of the rat diaphragm after prolonged triamcinolone treatment and nutritional deprivation. J Muscle Res Cell Motil 19:549–555PubMedCrossRefGoogle Scholar
  41. 41.
    Maes K, Agten A, Smuder A, Powers SK, Decramer M, Gayan-Ramirez G (2010) Corticosteroid effects on ventilator-induced diaphragm dysfunction in anesthetized rats depend on the dose administered. Respir Res 11:178–183PubMedCrossRefGoogle Scholar

Copyright information

© Copyright jointly held by Springer and ESICM 2011

Authors and Affiliations

  • Karen Maes
    • 1
  • Dries Testelmans
    • 1
  • Debby Thomas
    • 1
  • Marc Decramer
    • 1
  • Ghislaine Gayan-Ramirez
    • 1
    • 2
    Email author
  1. 1.Respiratory Muscle Research Unit, Laboratory of Pneumology and Respiratory DivisionKatholieke Universiteit LeuvenLeuvenBelgium
  2. 2.Labo AdemspierenLeuvenBelgium

Personalised recommendations